BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1406477)

  • 1. [Waldenström's macroglobulinemia: clinical aspects, diagnosis and therapy].
    Baldus M; Brass H
    Med Klin (Munich); 1992 Aug; 87(8):434-6. PubMed ID: 1406477
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: bilateral simultaneous central retinal vein occlusion in Waldenström's macroglobulinemia.
    Chanana B; Gupta N; Azad RV
    Optometry; 2009 Jul; 80(7):350-3. PubMed ID: 19545847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects of plasmapheresis in Waldenström's disease].
    Moulinier J; Servantie X; Mesnier F
    J Med Bord; 1967 Sep; 144(9):1295-300. PubMed ID: 4988704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia.
    Somer T; Ditzel J
    Bibl Haematol; 1981; (47):242-6. PubMed ID: 6802129
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.
    Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL
    Cancer Res; 1994 Jan; 54(1):165-8. PubMed ID: 8261437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Waldenström's macroglobulinemia].
    Mongin M
    Sem Hop; 1969 Jun; 45(30):2104-6. PubMed ID: 4309108
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia.
    Vos JM; Minnema MC; Wijermans PW; Croockewit S; Chamuleau ME; Pals ST; Klein SK; Delforge M; van Imhoff GW; Kersten MJ; ;
    Neth J Med; 2013 Mar; 71(2):54-62. PubMed ID: 23462052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Waldenström's macroglobulinemia].
    Brouet JC
    Rev Prat; 1979 Jan; 29(3):317-20, 323-4, 329. PubMed ID: 105399
    [No Abstract]   [Full Text] [Related]  

  • 15. Macroglobulinemia of Waldenström diagnosis and management.
    Messmore HL; Fareed J; Silberman S; Gawlik GM; Bermes EW
    Ann Clin Lab Sci; 1978; 8(4):310-7. PubMed ID: 99073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperviscosity syndrome in Waldenstrom's macroglobulinemia].
    Hrarat L; Qu L; Fajnkuchen F; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 Nov; 40(9):e323-e325. PubMed ID: 28992955
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Dimopoulos MA; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
    Bone Marrow Transplant; 2001 May; 27(10):1027-9. PubMed ID: 11438816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable complete remission after chemotherapy and rituximab in a case of Waldenström's macroglobulinemia with pleuropulmonary involvement.
    Capalbo S; Dargenio M; Delia M; Chiefa A; Diomede D; Napoli A; Ricco R; Liso V
    Ann Hematol; 2005 Sep; 84(9):625-6. PubMed ID: 15915349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bilateral occlusion of the central vein of the retina disclosing Waldenström's disease].
    Nabet L; Dufier JL; Cornu P; Junghers P; Chauvin JC; de Monteynard MS; Manderieux N; Haye C
    Bull Soc Ophtalmol Fr; 1989 Jan; 89(1):39-41. PubMed ID: 2513133
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.